ClinicalTrials.gg
CompletedNCT00018837Updated Jan 21, 2009

Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

An interventional study of Community Re-Entry Program: What is Schizophrenia in Schizophrenia and Schizophrenic Disorder, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2009-01-21.

Sponsored by US Department of Veterans Affairs · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.

02

Conditions studied

  • Schizophrenia
  • Schizophrenic Disorder

Browse trials for

03

In context

Schizophrenia

3,539 studies on the registry are indexed under Schizophrenia; 473 are open to participants now.

Browse Schizophrenia studies →

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 675 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18-65 years of age.
  2. DSM IV diagnosis of schizophrenia or schizoaffective disorder.
  3. Competent to give informed consent.
  4. Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.

Exclusion criteria

Exclusion Criteria:

  1. Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.
  2. History of substantial substance dependence 6 months prior to the study.
  3. Patients at high risk of suicide or other directed violence.
05

Study design

Phase
Not applicable
Intervention model
Parallel assignment

Interventions

  • BehavioralCommunity Re-Entry Program: What is Schizophrenia
06

Study locations

1 site
  • VA Greater Los Angeles Healthcare System
    Los Angeles, California 90073, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00018837
First posted
Jul 5, 2001
Start date
Apr 1998
Completion
Mar 2001
Last update
Jan 21, 2009
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2004. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion